$4.80
0.368.11%
Últ. Act.: Oct 20, 7:26 PM
$4.78
0.347.66%
Clover Health Investments (CLOV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Clover Health Investments (CLOV) publicó su última previsión de agosto 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $2.92B - $3B para el período.
En comparación con la previsión anterior, Clover Health Investments elevado redujo su previsión de ingresos desde un rango anterior de $2.81B - $2.92B.
Clover Health Investments ha emitido 11 actualizaciones de orientación entre el noviembre 7, 2022 y el agosto 5, 2026. During this period, the company raised its outlook 3 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.04 | $0.06 | $-0.07 | $-0.01 |
| Actual | $0.05 | $0.05 | $-0.10 | $-0.05 |
| Surprise | +25.0% | -16.7% | -42.9% | -400.0% |
| Revenue | ||||
| Estimate | $728.3M | $713.5M | $469.2M | $472.8M |
| Actual | $743.2M | $749.2M | $487.7M | $496.6M |
| Surprise | +2.05% | +5.01% | +3.94% | +5.04% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.01 | $-0.02 | $0.07 | $0.06 |
| Revenue | ||||
| Consensus | $739.9M | $721.9M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.05 | $0.04 | 25.0 % |
| Q1 | May 6, 2026 | $0.05 | $0.06 | -16.7 % |
| Q4 | Feb 26, 2026 | $-0.10 | $-0.07 | -42.9 % |
| Q3 | Nov 4, 2025 | $-0.05 | $-0.01 | -400.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $743.17M | $728.27M | 2.05 % |
| Q1 | May 6, 2026 | $749.20M | $713.48M | 5.01 % |
| Q4 | Feb 26, 2026 | $487.71M | $469.23M | 3.94 % |
| Q3 | Nov 4, 2025 | $496.65M | $472.81M | 5.04 % |